Pricing Log in Create free account

Kiora Pharmaceuticals, Inc. (KPRX) vs Lantern Pharma Inc. (LTRN)

Kiora Pharmaceuticals, Inc. and Lantern Pharma Inc. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and Lantern Pharma Inc. are of similar size ($10.7M and $10.0M). Across the 9 metrics below, Kiora Pharmaceuticals, Inc. leads on 6 and Lantern Pharma Inc. on 3.

Valuation

Metric KPRX LTRN Biotechnology median
P/E n/m n/m 8.50
P/S 0.79 n/m 9.71
P/B 0.88 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 n/m 0.64
EV/Sales (0.10) n/m 9.21
Earnings yield (103.07%) (257.14%) (33.15%)
Free cash flow yield (58.10%) (179.89%) (25.50%)

Profitability

Metric KPRX LTRN Biotechnology median
Gross margin 85.06% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.36%) (400.91%) (56.36%)
Return on assets (39.43%) (143.36%) (48.04%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX LTRN Biotechnology median
Revenue growth (TTM) 983.73% — 6.02%
EPS growth (last fiscal year) (403.45%) 18.65% 30.26%
Revenue growth, 5-year CAGR 88.72% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX LTRN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.97 1.96 4.72
Net debt to EBITDA 1.33 0.56 0.96

Dividend

Metric KPRX LTRN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KPRX LTRN Biotechnology median
Market cap 10.66m 9.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack